GeneQuantum Healthcare
PrivateLast Round
Series C
May 18, 2021
Total Funding Raised
$5.8M
Company Overview
GeneQuantum Healthcare is a biotechnology company that develops a new generation of bioconjugate therapeutics, such as antibody-drug conjugates (ADCs), to address unmet medical needs for cancer patients.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
GeneQuantum Healthcare Comparables
Compare GeneQuantum Healthcare with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Duality Biotherapeutics Inc | 85% | |
| Multitude Therapeutics | 84% | |
| Aimed Bio Inc. | 82% |
GeneQuantum Healthcare Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | May 18, 2021 | ||||
| Series B | Nov 19, 2020 | ||||
| Series B | Oct 1, 2020 | ||||
| VC Round | May 7, 2019 | ||||
| Series A | Mar 27, 2017 |
GeneQuantum Healthcare Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| TF Capital | Series A, VC Round |
| PICC Capital Equity Investment Co., Ltd. | Series C |
| Huagai Capital | VC Round |
| China Life Private Equity Investment | Series C |
| Oriza Seed Venture Capital | VC Round, Series A |
| Fontus Capital | VC Round, Series A |
| China Life Private Equity Investment Co., Ltd. | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 1, 2025
Launched iDiscovery and iConjugation systems for XDC discovery and manufacturing.
- Jul 1, 2025
Partnerships established with Henlius, Biohaven, and BrightGene.
GeneQuantum Healthcare Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about GeneQuantum Healthcare's valuation, stock price, and market status.
Is GeneQuantum Healthcare a public or private company?
GeneQuantum Healthcare is a private company.
What is the current stock price of GeneQuantum Healthcare?
GeneQuantum Healthcare is a private company with no public stock price. No recent secondary market data is available.
How much is GeneQuantum Healthcare worth (valuation)?
Valuation information for GeneQuantum Healthcare is not publicly available.
Can I buy GeneQuantum Healthcare stock?
GeneQuantum Healthcare shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was GeneQuantum Healthcare's last funding round?
GeneQuantum Healthcare's most recent funding round was Series C on May 18, 2021.
Who are the main investors in GeneQuantum Healthcare?
Key investors in GeneQuantum Healthcare include Huagai Capital, China Life Private Equity Investment, Oriza Seed Venture Capital, Fontus Capital.
Will GeneQuantum Healthcare IPO soon?
No public IPO plans have been announced for GeneQuantum Healthcare.
How can I track GeneQuantum Healthcare secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor GeneQuantum Healthcare's secondary market activity and sign up for updates.